Connection
Bradley Corr to Folate Receptor 1
This is a "connection" page, showing publications Bradley Corr has written about Folate Receptor 1.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.230 |
|
|
|
-
Alvarez Secord A, Lewin SN, Murphy CG, Cecere SC, Barquín A, Gálvez-Montosa F, Mathews CA, Konecny GE, Ray-Coquard I, Oaknin A, Rubio Pérez MJ, Bonaventura A, Diver EJ, Ayuk SM, Wang Y, Corr BR, Salutari V. The efficacy and safety of mirvetuximab soravtansine in FRa-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial. Ann Oncol. 2025 Mar; 36(3):321-330.
Score: 0.230